The French start-up Rainbow was founded in 2019 in Paris by five entrepreneurs who raised €1 million from private investors such as La Fabrique Cookies and Michel and Augustin. Its credo: to offer a varied range of products based on hemp. It presents itself as a “cannabis tech” company.
Based in Paris and with seven employees, Rainbow brings together five partners, including the founding team of Vaïvaï, which imported coconut water into France (Emmanuel Jesberger, Gaétan Laederich and Camille Brocco), Ludovic Rachou, founder of the innovative confectionery brands One Gum and Bonsaï, and Alison Ouvrier-Neyret, doctor of pharmacy, who has developed many cosmetic brands.
This inventive world of cannabis innovations where new entrants are constantly shaking things up is always on the move, as are the many events driving today’s business news. Don’t miss a thing; download our free companion app, Born2Invest.
Confectionary and Cosmetics
Rainbow launched its wellness brand, Kaya, in July and wants to continue with its Peace & Skin cosmetic brand to relax consumers with the virtues of hemp and other adaptogenic plants. “Hemp has a lot of potential because its benefits are not well known, the crop is undervalued and a victim of cannabis stereotypes. Moreover, its use is a victim of administrative blockage in France, which is why Kaya was first launched in the United Kingdom,” explains Ludovic Rachou, the founder.
“Relax with products that everyone loves” is the Kaya promise. Chewing gum, vitamin-rich gummy bears, oils to put under the tongue; their products are accessible, simple and effective. They are made from adaptogenic plants and cannabidiol (CBD) found in hemp, they are called “THC free” because they contain no THC (Tetrahydrocannabinol). It is indeed THC that is of interest to recreational cannabis users; apart from Kaya’s products, they contain CBD, which is not a psychotropic drug.
They are not currently produced in France. But the hemp comes from French cultivation.
Hemp bags made in France
In addition to hemp flower-based products, the start-up also plans to partner with the textile company Les Tissages de Charlieu (near Roanne, in the Loire) to produce more durable, reusable bags made from the fiber.
As an alternative to kraft and cotton bags, future hemp fiber bags would be eco-responsible, thanks to a French manufacture made from hemp grown on the territory with “a very good carbon footprint” and reusable.
French law concerning the use of CBD remains unclear
The development of hemp start-ups remains limited in France due to legislation. Ludovic Mendes, a member of parliament (LREM) from the Moselle constituency, believes that there is “a lot of added value in this product” that is the CBD. However, French legislation on this subject still seems to be flawed because, unlike THC, which is considered a narcotic and falls under Article 222-37 of the Penal Code, CBD as such is not considered a narcotic product and is therefore not prohibited by law. However, CBD may be marketed in France only under the following cumulative conditions: the varieties of hemp grown must appear on the exhaustive list set out in Article 2 of the Order of 22 August 1990; the cannabis plant must have a THC content of less than 0.2% and only its seeds and fibers may be used; the product must not contain any trace of THC. This article does not authorize the marketing and use of hemp leaves or flowers.
It allows the use of certain varieties and parts of hemp for industrial and commercial purposes, but the communications by sellers of CBD products must not make any therapeutic claims. In France, only medicines authorized by the ANSM or the European Medicines Agency can be presented in this way.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in USINE NOUVELLE, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
4 ways startups can become business intelligent
In order to make the most out of the business intelligence methodology of data processing, you should use the right...
bZx Hack: $8 million in ETH, LINK, and Stablecoins stolen
Users of the protocol and the team behind bZx itself used Twitter to warn DeFi users that something was wrong...
First harvest of German medical cannabis is likely to be delayed again
As a consequence of the coronavirus pandemic, the first harvest of German medical cannabis will probably be delayed again by...
The fintech sector in Italy is small but has high potential to support the economy
The Italian economy was one of the hardest hit economies in Europe, because of the lockdown caused by the coronavirus...
Grünenthal closes a deal with Teva to market teriparatide
The number of old people suffering from osteoporosis is increasing every year. The companies Grünenthal and Teva partnered in order...
Featured6 days ago
Switzerland strengthens its position as a crypto friendly country
Featured7 days ago
ESG funds in Germany break the €100 billion mark
Business7 days ago
Risks and benefits of investing in IT in 2020
Business6 days ago
How will changes to Facebook’s terms of service affect your business?